Related Experiment Video
Updated: Mar 7, 2026

08:47
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
12.1K
Ertapenem-Induced Encephalopathy in a Patient With Normal Renal Function
S Scott Sutton1, Mark Jumper1, Sean Cook2
1University of South Carolina, Columbia, SC, USA.
Journal of Investigative Medicine High Impact Case Reports
|February 17, 2017
Summary
Ertapenem can cause neurotoxicity, specifically encephalopathy, even in patients with normal kidney function. Symptoms resolved after stopping the drug, indicating a probable adverse reaction.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- Drug-induced neurotoxicity is a rare but serious adverse effect.
- Ertapenem, a carbapenem antibiotic, has been associated with neurotoxicity.
- Encephalopathy is a diffuse brain disease affecting function and structure.
Purpose of the Study:
- To report a case of ertapenem-induced encephalopathy in a patient with normal renal function.
- To highlight the potential for ertapenem to cause neurotoxicity independent of renal impairment.
- To assess the causality of ertapenem in the observed adverse event.
Main Methods:
- Case report of a patient who developed neurological symptoms after ertapenem administration.
- Clinical assessment of neurological symptoms including altered mental status, hallucinations, and dystonic movements.
- Utilized the Naranjo Scale to evaluate the probability of an adverse drug reaction.
Main Results:
- The patient developed encephalopathy with altered mental status, hallucinations, and dystonia.
- Symptoms significantly improved after discontinuation of ertapenem.
- The Naranjo Scale score was 7, indicating a probable adverse drug reaction.
Conclusions:
- Ertapenem can induce encephalopathy even in patients with preserved renal function.
- The temporal relationship and symptom resolution support ertapenem as the causative agent.
- This case adds to the understanding of ertapenem-associated neurotoxicity.
More Related Videos
Related Concept Videos
Renal Failure: Dose Adjustments
547
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
547
Renal Drug Excretion: Overview
869
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
869
Renal Drug Excretion: Tubular Secretion
1.0K
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
1.0K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
420
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
420
Renal Drug Excretion: Tubular Reabsorption
1000
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
1000
Renal Drug Excretion: Glomerular Filtration
1.6K
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
1.6K

